AsiaPhos anticipates rebound in Q2 2024

The company reported a net loss of $0.38m in H1 2023.

AsiaPhos Limited anticipates its Q1 and H1 2024 net earnings to improve on a year-on-year basis, compared to the net loss recorded in the same quarter in 2023.

The rebound is influenced by “fair value gain on other equity investment," AsiaPhos said in an SGX filing.

It is also partly thanks to gains on transfer of foreign currency translation reserve upon the deconsolidation of its foreign subsidiary, Sichuan Rongdafeng Chemical Co. (Rongdafeng), following the handover of Rongdafeng's control to Sichuan Rongda Yuexiang Chemical Group Co. (Rongda) related to the disposal of the P4 Plant.

In the same half last year, the SGX-listed group narrowed its net loss to $0.38m.

Full details regarding its Q2 profits will be disclosed on or before 14 August.

Follow the link for more news on

SGX

stock exchange

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia